GSK's phase 3 trial shows Blenrep combined with BorDex improves overall survival in relapsed multiple myeloma.

H.C. Wainwright analyst Ram Selvaraju has reiterated their neutral stance on RAPT stock, giving a Hold rating yesterday. Ram Selvaraju has given his Hold rating due to a combination of factors ...

Harvey Jones thought he was getting a bargain when he snapped up these too much-loved FTSE 100 dividend growth stocks. Now they're getting on his nerves. The post These 2 former stock market darlings ...

The Shocking Truth" How did Zantac, once the world's most popular drug for acid reflux and heartburn, turn into a toxic ...

While the numbers slumped in Q3 2024, this was expected, especially as reported earnings absorbed Zantac related payouts. They are unlikely to impact full year figures, however. In the meantime ...

Having removed uncertainty by resolving the vast majority of Zantac litigation cases in the ... The Warwickshire-based firm last month scaled back estimates for 2024 due to supply chain disruption ...

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug. GSK suffered ...

YORK, Maine — The Purple Palace is back on the market after being under contract this summer, the deal falling through. Realtor Joseph Itaaliander said he could not elaborate on why the sale did ...

The High Park Alhambra Church, once a beacon of worship and then a promising new condo development, is now more of a partially built ruin wrapped in scaffolding, its future uncertain. Located at ...

Notably, GSK’s previously sold antacid Zantac may have caused cancer in some ... From a valuation perspective, GSK, with a $77.0 billion market cap, is already a pharma giant across several ...

Kash Doll has boldly announced that she is officially back on the market following her split from Tracy T. This revelation comes just months after the couple parted ways, a decision that followed ...